Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema

Laryngoscope

Volumn 118, Issue 12, 2008, Pages 2115-2120

  Roberts, Daniel S ^a   Mahoney, Elizabeth J ^a,b   Hutchinson, Christoph T ^a   Aliphas, Avner ^a   Grundfast, Kenneth M ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

ACE inhibitor; Angioedema; Recurrent angioedema

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FACE EDEMA; FEMALE; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL ERROR; MEDICAL RECORD REVIEW; MEDICATION ERROR; MOUTH EDEMA; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; AIRWAY OBSTRUCTION; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; EAR NOSE THROAT DISEASE; ETHNIC GROUP; INCIDENCE; MIDDLE AGED; RETREATMENT; STATISTICS; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AIRWAY OBSTRUCTION; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BOSTON; CROSS-SECTIONAL STUDIES; DRUG HYPERSENSITIVITY; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OTORHINOLARYNGOLOGIC DISEASES; RECURRENCE; RETREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 58149361866     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318182f805     Document Type: Article

References (17)

1. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol 1999; 48:861-865.
2. Rai MR, Amen F., Idrees F. Angiotensin-converting enzyme inhibitor related angioedema and the anaesthetist. Anaesthesia 2004; 59:283-289.
3. Megerian CA, Arnold JE, Berger M. Angioedema: 5 years' experience, with a review of the disorder's presentation and treatment [Review]. Laryngoscope 1992; 102:256-260.
4. Messerli FH, Nussberger J. Vasopeptidase inhibition and angio-oedema. Lancet 2000; 356:608-609.
5. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin convertingenzyme inhibition. JAMA 1988; 260:967-970.
6. Inman WH, Rawson NS, Wilton LV, Pearce GL, Speirs CJ. Postmarketing surveillance of enalapril. I. Results of prescription-event monitoring. BMJ 1988; 297:826-829.
7. Morimoto T., Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004; 10:499-450.
8. Brown NJ, Snowden M., Griffin MR. Recurrent angiotensinconverting enzyme inhibitor-associated angioedema. JAMA 1997; 278:232-233.
9. Sondhi D., Lippmann M., Murali G. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest 2004; 126:400-404.
10. Ishoo E., Shah UK, Grillone GA, Stram JR, Fuleihan NS. Predicting airway risk in angioedema: staging system based on presentation. Otolaryngol Head Neck Surg 1999; 121:263-268.
11. Cohen AL, Rivara F., Marcuse EK, McPhillips H., Davis R. Are language barriers associated with serious medical events in hospitalized pediatric patients? Pediatrics 2005; 116: 575-579.
12. Lombardi C., Crivellaro M., Dama A., Senna G., Gargioni S., Passalacqua G. Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categories. Chest 2005; 128:976-979.
13. Guo X., Dick L. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature. J Okla State Med Assoc 1999; 92:71-73.
14. Malde B., Regalado J., Greenberger PA. Investigation of angioedema associated with the use of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007; 98:57-63.
15. Agostoni A., Cicardi M., Cugno M., et al. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 1999; 44:21-25.
16. Golden WE, Cleves MA, Heard JK, et al. Frequency and recognition of angiotensin-converting enzyme inhibitorassociated angioneurotic edema. Clin Perform Qual Health Care 1993; 1:205-207.
17. Jones TA, Como JA. Assessment of medication errors that involved drug allergies at a university hospital. Pharmacotherapy 2003; 23:855-860.